科技浪潮与资本远见交汇，2025资本市场香港论坛成功举办

Group 1 - The forum held in Hong Kong focused on the intersection of technology and capital markets, discussing new growth drivers and opportunities in asset allocation in China by 2026 [1][4] - AI is transforming the pharmaceutical industry from drug discovery to precision medicine, as highlighted by experts at the forum [3][2] - The asset management industry is experiencing a significant impact from AI, with its integration into quantitative investment and data processing [3][2] Group 2 - Morgan Stanley's chief China equity strategist presented a positive outlook for the Chinese stock market, indicating a "slow bull" market driven by earnings improvement and policy support [5][4] - Global investors are focusing on diversified and balanced asset allocation strategies in the context of a low-interest-rate environment [5][4] - Insurance capital is increasingly favoring equity assets with strong profitability and high dividend characteristics, reflecting a proactive choice to engage with the long-term value of the Chinese equity market [7][6] Group 3 - The forum provided critical insights for investment strategies leading up to 2026, emphasizing the importance of embracing technological changes and maintaining a long-term value approach in the asset management industry [7][6]